StockData
Nu Skin Enterprises, Inc. logo

Nu Skin Enterprises, Inc. (NUS) stock

NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3070% below fair value
$3.87+0.09 (+2.38%)

Close on Nov 18, 2026Market cap $188.38MP/E –Yield –

Nu Skin Enterprises free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Nu Skin Enterprises's free cash flow for the twelve months ending Sep 30, 2026 was -$26.26M, down 149.2% year over year. For fiscal 2025 it was $46.01M, down 34.4% from the year before. Over ten years it grew -16.1% a year on average. The highest annual figure on record is $345.07M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$46.01M-34.4%
FY2024Dec 31, 2024$70.16M+16.6%
FY2023Dec 31, 2023$60.15M+22.7%
FY2022Dec 31, 2022$49.01M-32.8%
FY2021Dec 31, 2021$72.97M-76.9%
FY2020Dec 31, 2020$315.32M+181.9%
FY2019Dec 31, 2019$111.86M-15.5%
FY2018Dec 31, 2018$132.37M-45.4%
FY2017Dec 31, 2017$242.40M+7.7%
FY2016Dec 31, 2016$225.04M-15.2%
FY2015Dec 31, 2015$265.49M–
FY2014Dec 31, 2014-$157.94M-145.8%
FY2013Dec 31, 2013$345.07M+61.0%
FY2012Dec 31, 2012$214.33M+17.4%
FY2011Dec 31, 2011$182.51M+36.1%
FY2010Dec 31, 2010$134.10M+17.9%
FY2009Dec 31, 2009$113.73M+30.3%
FY2008Dec 31, 2008$87.30M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$19.47M-210.9%
Q2 FY2026Jun 30, 2026$4.99M-86.1%
Q1 FY2026Mar 31, 2026-$17.63M–
Q4 FY2025Dec 31, 2025$5.86M-55.6%
Q3 FY2025Sep 30, 2025$17.57M-23.1%
Q2 FY2025Jun 30, 2025$35.78M-17.0%
Q1 FY2025Mar 31, 2025-$13.20M–
Q4 FY2024Dec 31, 2024$13.20M-60.9%
Q3 FY2024Sep 30, 2024$22.84M-41.6%
Q2 FY2024Jun 30, 2024$43.08M+107.0%
Q1 FY2024Mar 31, 2024-$8.96M–
Q4 FY2023Dec 31, 2023$33.78M+187.7%
Q3 FY2023Sep 30, 2023$39.12M+1210.1%
Q2 FY2023Jun 30, 2023$20.81M-43.8%
Q1 FY2023Mar 31, 2023-$33.56M–
Q4 FY2022Dec 31, 2022$11.74M-87.1%
Q3 FY2022Sep 30, 2022$2.99M-82.1%
Q2 FY2022Jun 30, 2022$37.02M+1042.8%
Q1 FY2022Mar 31, 2022-$2.74M–
Q4 FY2021Dec 31, 2021$91.28M+14.6%
Q3 FY2021Sep 30, 2021$16.68M-83.0%
Q2 FY2021Jun 30, 2021$3.24M-96.3%
Q1 FY2021Mar 31, 2021-$38.23M-177.0%
Q4 FY2020Dec 31, 2020$79.68M+117.6%
Q3 FY2020Sep 30, 2020$98.25M+227.7%
Q2 FY2020Jun 30, 2020$87.75M+30.6%
Q1 FY2020Mar 31, 2020$49.64M–
Q4 FY2019Dec 31, 2019$36.62M-39.8%
Q3 FY2019Sep 30, 2019$29.98M-37.6%
Q2 FY2019Jun 30, 2019$67.21M+80.3%
Q1 FY2019Mar 31, 2019-$21.95M–
Q4 FY2018Dec 31, 2018$60.81M-51.6%
Q3 FY2018Sep 30, 2018$48.05M-20.7%
Q2 FY2018Jun 30, 2018$37.27M-26.7%
Q1 FY2018Mar 31, 2018-$13.77M-355.0%
Q4 FY2017Dec 31, 2017$125.56M+68.2%
Q3 FY2017Sep 30, 2017$60.56M–
Q2 FY2017Jun 30, 2017$50.88M–
Q1 FY2017Mar 31, 2017$5.40M–
Q4 FY2016Dec 31, 2016$74.63M–

More Nu Skin Enterprises figures

See a number that looks wrong?